ZINC OXIDE

ZINC OXIDE was reported 2103 times

ZINC OXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 148 0.4884
1 AMYLOID ARTHROPATHY 29 0.4143
2 TRANSFERRIN SATURATION ABNORMAL 5 0.2941
3 FEMALE GENITAL TRACT FISTULA 159 0.0930
4 TOTAL LUNG CAPACITY INCREASED 23 0.0846
5 CARBUNCLE 23 0.0813
6 PRODUCT ADMINISTRATION ISSUE 14 0.0670
7 RADICULOPATHY 154 0.0584
8 ANAL INFLAMMATION 37 0.0579
9 CHRONIC SINUSITIS 198 0.0527
10 PROCTITIS 147 0.0524
11 SARS-COV-2 TEST NEGATIVE 33 0.0489
12 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 23 0.0440
13 MACULAR DEGENERATION 460 0.0385
14 ASYMPTOMATIC BACTERIURIA 5 0.0368
15 MONOCLONAL IMMUNOGLOBULIN PRESENT 22 0.0289
16 ANAL EROSION 3 0.0273
17 WRIST DEFORMITY 15 0.0244
18 DERMATOPHYTOSIS 5 0.0176
19 SERUM FERRITIN ABNORMAL 5 0.0156
20 GRAFT VERSUS HOST DISEASE IN INTESTINE 2 0.0154
21 HYPOTHALAMO-PITUITARY DISORDER 22 0.0151
22 NASAL FLARING 2 0.0148
23 VAGINAL DISCHARGE 148 0.0146
24 PARAESTHESIA ORAL 199 0.0138
25 MUCOSAL HYPERTROPHY 2 0.0135
26 MIGRAINE WITHOUT AURA 4 0.0133
27 NEUROBLASTOMA 5 0.0131
28 NUCLEAR MAGNETIC RESONANCE IMAGING 2 0.0120
29 ORAL CANDIDIASIS 150 0.0114
30 CREATININE RENAL CLEARANCE ABNORMAL 5 0.0108
31 PULMONARY PAIN 30 0.0103
32 GASTROSTOMY TUBE SITE COMPLICATION 2 0.0100
33 DERMATITIS DIAPER 7 0.0099
34 LICE INFESTATION 2 0.0095
35 NODULAR RASH 2 0.0090
36 EPILEPTIC ENCEPHALOPATHY 2 0.0090
37 MENINGOENCEPHALITIS HERPETIC 4 0.0089
38 FEEDING INTOLERANCE 4 0.0089
39 PROCTALGIA 56 0.0087
40 NEUROGENIC BOWEL 2 0.0084
41 GINGIVAL ERYTHEMA 7 0.0081
42 FIBROSIS 22 0.0071
43 ALVEOLAR OSTEITIS 3 0.0071
44 JARISCH-HERXHEIMER REACTION 5 0.0070
45 BURSA DISORDER 2 0.0069
46 PROCEDURAL PAIN 190 0.0068
47 JAUNDICE CHOLESTATIC 23 0.0065
48 HYPOMANIA 23 0.0062
49 SKIN CANDIDA 3 0.0057
50 CHRONIC RESPIRATORY DISEASE 2 0.0057
51 FREQUENT BOWEL MOVEMENTS 153 0.0057
52 XEROSIS 7 0.0057
53 FAT EMBOLISM 2 0.0056
54 RHINITIS ALLERGIC 25 0.0056
55 PNEUMONIA STREPTOCOCCAL 6 0.0055
56 TINEA INFECTION 6 0.0054
57 INJECTION SITE ULCER 5 0.0053
58 LIFE EXPECTANCY SHORTENED 3 0.0053
59 NASAL POLYPS 26 0.0053
60 CAPILLARY DISORDER 2 0.0052
61 AORTIC CALCIFICATION 3 0.0052
62 SARCOIDOSIS 23 0.0048
63 ENTEROCOCCUS TEST POSITIVE 3 0.0046
64 HAEMANGIOMA OF SKIN 2 0.0046
65 FINGER DEFORMITY 22 0.0045
66 DYSLIPIDAEMIA 23 0.0045
67 LICHEN SCLEROSUS 3 0.0044
68 ECZEMA HERPETICUM 2 0.0043
69 OVERWEIGHT 23 0.0043
70 DISSEMINATED ASPERGILLOSIS 2 0.0042
71 LANGUAGE DISORDER 9 0.0042
72 LENTIGO 2 0.0040
73 COLITIS 151 0.0040
74 METASTATIC SQUAMOUS CELL CARCINOMA 2 0.0039
75 BRONCHIECTASIS 26 0.0039
76 RECTAL HAEMORRHAGE 165 0.0038
77 RESPIRATORY SYNCYTIAL VIRUS BRONCHIOLITIS 3 0.0038
78 MUSCLE DISCOMFORT 3 0.0038
79 BRONCHOPULMONARY DYSPLASIA 3 0.0037
80 GRANULOMA SKIN 3 0.0037
81 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 3 0.0036
82 MILK ALLERGY 2 0.0036
83 ENTEROVIRUS INFECTION 3 0.0035
84 EUSTACHIAN TUBE DYSFUNCTION 2 0.0035
85 COLITIS ULCERATIVE 152 0.0034
86 CANDIDA SEPSIS 3 0.0033
87 GRUNTING 2 0.0033
88 CEREBRAL ASPERGILLOSIS 2 0.0033
89 INFUSION RELATED REACTION 201 0.0030
90 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 215 0.0030
91 RENAL CYST 24 0.0030
92 ACCIDENT 36 0.0030
93 CARDIAC MURMUR 26 0.0030
94 KERATOACANTHOMA 2 0.0029
95 HAEMATOCHEZIA 160 0.0029
96 ANGULAR CHEILITIS 2 0.0029
97 KIDNEY FIBROSIS 5 0.0029
98 LEIOMYOMA 2 0.0029
99 ANTIBODY TEST ABNORMAL 2 0.0028
100 APLASTIC ANAEMIA 14 0.0027
101 DYSAESTHESIA 8 0.0026
102 DEBRIDEMENT 2 0.0026
103 PURPURA 23 0.0026
104 NEPHROPATHY 24 0.0026
105 METAPNEUMOVIRUS INFECTION 2 0.0026
106 BICYTOPENIA 5 0.0025
107 GINGIVAL INFECTION 2 0.0025
108 CHRONIC RESPIRATORY FAILURE 3 0.0025
109 DECUBITUS ULCER 20 0.0025
110 GUTTATE PSORIASIS 2 0.0024
111 BOTULISM 2 0.0024
112 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
113 LUNG NEOPLASM 10 0.0023
114 MEAN CELL VOLUME INCREASED 6 0.0023
115 RHINOVIRUS INFECTION 9 0.0023
116 BODY HEIGHT DECREASED 24 0.0022
117 PNEUMONIA VIRAL 7 0.0022
118 CERUMEN IMPACTION 2 0.0022
119 RHONCHI 3 0.0022
120 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
121 BIOPSY 2 0.0022
122 HAEMORRHOIDS 42 0.0022
123 FACIAL ASYMMETRY 2 0.0021
124 ANIMAL SCRATCH 2 0.0021
125 COLON ADENOMA 2 0.0020
126 IMPETIGO 3 0.0020
127 DYSPEPSIA 197 0.0020
128 DEVICE RELATED SEPSIS 4 0.0020
129 VASCULAR DEVICE INFECTION 9 0.0020
130 SCHIZOPHRENIA 24 0.0020
131 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
132 IMPLANT SITE SWELLING 2 0.0020
133 BODY TEMPERATURE INCREASED 39 0.0019
134 HYPOPERFUSION 2 0.0019
135 NEUROMYOPATHY 2 0.0019
136 OBESITY 29 0.0018
137 CLOSTRIDIUM TEST POSITIVE 4 0.0018
138 GASTROINTESTINAL ULCER HAEMORRHAGE 2 0.0018
139 BLOOD FIBRINOGEN DECREASED 2 0.0018
140 OPEN REDUCTION OF FRACTURE 2 0.0017
141 ACUTE PRERENAL FAILURE 2 0.0017
142 JOINT RANGE OF MOTION DECREASED 23 0.0017
143 FANCONI SYNDROME ACQUIRED 3 0.0017
144 ESCHERICHIA BACTERAEMIA 4 0.0017
145 SCIATICA 27 0.0017
146 MONOCYTE COUNT DECREASED 2 0.0016
147 HYPERPARATHYROIDISM SECONDARY 4 0.0016
148 BRONCHIAL SECRETION RETENTION 2 0.0016
149 CANCER PAIN 4 0.0016
150 CUSHINGOID 5 0.0016
151 CHOLELITHIASIS 49 0.0015
152 SKIN DISCOMFORT 4 0.0015
153 CARBON DIOXIDE INCREASED 2 0.0015
154 APPLICATION SITE INFLAMMATION 2 0.0014
155 GRANULOMA 5 0.0014
156 INCISIONAL HERNIA 2 0.0014
157 NEUROGENIC BLADDER 3 0.0014
158 NEUROENDOCRINE TUMOUR 2 0.0014
159 CATAPLEXY 2 0.0014
160 GENITAL RASH 2 0.0014
161 HEPATIC STEATOSIS 26 0.0014
162 ACUTE ABDOMEN 2 0.0014
163 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
164 FOOT DEFORMITY 15 0.0014
165 FAILURE TO THRIVE 7 0.0013
166 HEPATOTOXICITY 30 0.0013
167 METABOLIC ENCEPHALOPATHY 4 0.0013
168 SYNOVITIS 24 0.0013
169 PEMPHIGOID 10 0.0013
170 REBOUND ACID HYPERSECRETION 4 0.0013
171 MEAN CELL VOLUME DECREASED 2 0.0013
172 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
173 PUSTULE 3 0.0013
174 SKIN EROSION 4 0.0012
175 KNEE ARTHROPLASTY 26 0.0012
176 RALES 7 0.0012
177 EXPOSURE TO SARS-COV-2 2 0.0012
178 ENTERITIS INFECTIOUS 2 0.0012
179 MILIARIA 2 0.0012
180 FEBRILE NEUTROPENIA 76 0.0011
181 BRONCHIOLITIS 4 0.0011
182 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
183 BREAST SWELLING 3 0.0011
184 EAR CONGESTION 3 0.0011
185 MONOPARESIS 2 0.0011
186 ESSENTIAL HYPERTENSION 2 0.0011
187 NEPHROGENIC ANAEMIA 5 0.0011
188 BLOOD BILIRUBIN INCREASED 29 0.0011
189 LUNG CONSOLIDATION 3 0.0011
190 LIMB INJURY 29 0.0011
191 LIVING IN RESIDENTIAL INSTITUTION 2 0.0011
192 MECHANICAL VENTILATION 2 0.0011
193 PNEUMATOSIS INTESTINALIS 3 0.0011
194 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
195 HYPOALBUMINAEMIA 8 0.0010
196 OCCULT BLOOD POSITIVE 2 0.0010
197 ANAEMIA 193 0.0010
198 BACTERAEMIA 12 0.0010
199 HYPERNATRAEMIA 5 0.0010
200 MUCOSAL DRYNESS 2 0.0010
201 MYELOFIBROSIS 3 0.0010
202 JOINT STIFFNESS 26 0.0010
203 FUNGAL SKIN INFECTION 4 0.0010
204 ARTHROPATHY 55 0.0010
205 EMBOLISM VENOUS 3 0.0010
206 RECTAL CANCER 3 0.0010
207 PERIPHERAL VASCULAR DISORDER 5 0.0010
208 HYPERPARATHYROIDISM 2 0.0010
209 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
210 MICROCYTIC ANAEMIA 2 0.0010
211 PNEUMONIA ASPIRATION 24 0.0010
212 LIVEDO RETICULARIS 2 0.0010
213 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
214 HYPERPHOSPHATAEMIA 2 0.0009
215 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
216 DYSSTASIA 27 0.0009
217 ONYCHOMYCOSIS 4 0.0009
218 HAEMORRHAGIC ANAEMIA 4 0.0009
219 CONSTIPATION 198 0.0009
220 MIDDLE EAR EFFUSION 2 0.0009
221 CONGENITAL ANOMALY 7 0.0009
222 FAECES PALE 2 0.0009
223 PYREXIA 311 0.0009
224 NEPHRITIS 3 0.0009
225 WEIGHT DECREASED 248 0.0009
226 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
227 BLOOD LOSS ANAEMIA 2 0.0009
228 METASTASES TO MENINGES 2 0.0009
229 PUSTULAR PSORIASIS 3 0.0009
230 DRUG LEVEL ABOVE THERAPEUTIC 4 0.0009
231 SKIN ATROPHY 5 0.0009
232 HYPOVOLAEMIA 5 0.0009
233 ARTERIOSCLEROSIS 8 0.0008
234 ERYTHEMA 174 0.0008
235 SKIN ABRASION 4 0.0008
236 ABDOMINAL PAIN 193 0.0008
237 LYMPHADENITIS 2 0.0008
238 FOETAL GROWTH RESTRICTION 5 0.0008
239 HEPATIC ENZYME INCREASED 56 0.0008
240 PSEUDOMONAS INFECTION 7 0.0008
241 HYPOPHOSPHATAEMIA 6 0.0008
242 MOVEMENT DISORDER 26 0.0008
243 HYPERVOLAEMIA 4 0.0008
244 DEVICE INFUSION ISSUE 2 0.0008
245 PARANASAL SINUS DISCOMFORT 3 0.0008
246 DERMATITIS CONTACT 9 0.0008
247 INCREASED BRONCHIAL SECRETION 2 0.0008
248 PSYCHOTIC DISORDER 23 0.0008
249 CACHEXIA 4 0.0008
250 LOWER RESPIRATORY TRACT INFECTION 35 0.0008
251 WOUND SECRETION 3 0.0008
252 BONE DENSITY DECREASED 24 0.0008
253 LUNG OPACITY 2 0.0008
254 CEREBRAL ATROPHY 3 0.0008
255 AZOTAEMIA 3 0.0008
256 BLOOD SODIUM INCREASED 2 0.0007
257 ABDOMINAL RIGIDITY 2 0.0007
258 OSTEOARTHRITIS 31 0.0007
259 CLONUS 2 0.0007
260 HYPERCHOLESTEROLAEMIA 7 0.0007
261 DRUG SCREEN FALSE POSITIVE 2 0.0007
262 MACULE 2 0.0007
263 SKIN DISORDER 24 0.0007
264 MALNUTRITION 8 0.0007
265 ANAL HAEMORRHAGE 2 0.0007
266 OSTEOPOROSIS 29 0.0007
267 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
268 DUODENAL ULCER HAEMORRHAGE 2 0.0007
269 LIP PAIN 2 0.0007
270 STAPHYLOCOCCAL BACTERAEMIA 3 0.0007
271 PSORIATIC ARTHROPATHY 28 0.0007
272 ADENOVIRUS INFECTION 2 0.0007
273 HAEMOTHORAX 2 0.0007
274 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
275 PARONYCHIA 3 0.0007
276 GINGIVAL SWELLING 3 0.0007
277 LYMPHOCYTE COUNT DECREASED 12 0.0007
278 ABDOMINAL ABSCESS 3 0.0007
279 DECREASED INTEREST 4 0.0007
280 DRUG ERUPTION 12 0.0007
281 DERMATITIS 14 0.0007
282 INCONTINENCE 7 0.0007
283 DERMATITIS ACNEIFORM 4 0.0007
284 HYPOXIA 23 0.0007
285 CHEST X-RAY ABNORMAL 2 0.0007
286 EYE OPERATION 3 0.0007
287 BLOOD BLISTER 2 0.0006
288 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
289 BLOOD CREATININE DECREASED 2 0.0006
290 ABDOMINAL ADHESIONS 2 0.0006
291 BLADDER PAIN 2 0.0006
292 HUMERUS FRACTURE 3 0.0006
293 RASH VESICULAR 3 0.0006
294 RESPIRATORY DISTRESS 17 0.0006
295 BACTERIAL SEPSIS 2 0.0006
296 HYPOVENTILATION 2 0.0006
297 HEPATIC NEOPLASM 2 0.0006
298 OEDEMA MOUTH 2 0.0006
299 HAEMATOCRIT DECREASED 12 0.0006
300 CORONAVIRUS INFECTION 4 0.0006
301 END STAGE RENAL DISEASE 11 0.0006
302 MALAISE 264 0.0006
303 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
304 EOSINOPHIL COUNT INCREASED 5 0.0006
305 CYTOKINE RELEASE SYNDROME 12 0.0006
306 CEREBRAL HAEMATOMA 2 0.0006
307 METASTASES TO SPINE 2 0.0006
308 CANDIDA INFECTION 10 0.0006
309 HEPATIC CYST 2 0.0006
310 BRONCHOPNEUMONIA 2 0.0006
311 LUNG NEOPLASM MALIGNANT 24 0.0006
312 LEFT VENTRICULAR FAILURE 2 0.0006
313 ORAL PAIN 13 0.0006
314 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 30 0.0006
315 AORTIC STENOSIS 2 0.0006
316 PAPULE 4 0.0006
317 FACIAL PARESIS 2 0.0006
318 ANORECTAL DISCOMFORT 3 0.0006
319 LIVER DISORDER 25 0.0006
320 FIBRIN D DIMER INCREASED 2 0.0006
321 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
322 ANAL FISSURE 3 0.0006
323 ANAL ABSCESS 3 0.0006
324 SKIN LACERATION 6 0.0006
325 HYDROCEPHALUS 3 0.0006
326 DEVICE KINK 2 0.0005
327 FAECALOMA 3 0.0005
328 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
329 ARTHROPOD BITE 4 0.0005
330 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
331 STREPTOCOCCAL INFECTION 3 0.0005
332 CONJUNCTIVITIS 10 0.0005
333 MUSCULOSKELETAL PAIN 28 0.0005
334 HYDRONEPHROSIS 4 0.0005
335 CATHETER SITE INFECTION 2 0.0005
336 GASTRIC INFECTION 2 0.0005
337 WHEEZING 31 0.0005
338 BOWEL MOVEMENT IRREGULARITY 4 0.0005
339 HERPES VIRUS INFECTION 3 0.0005
340 RENAL FAILURE CHRONIC 4 0.0005
341 DEVICE RELATED INFECTION 8 0.0005
342 ATELECTASIS 5 0.0005
343 FAECES HARD 2 0.0005
344 THERAPY PARTIAL RESPONDER 8 0.0005
345 PULMONARY HAEMORRHAGE 4 0.0005
346 ELECTROCARDIOGRAM ABNORMAL 4 0.0005
347 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 3 0.0005
348 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
349 SKIN ULCER 13 0.0005
350 MYASTHENIA GRAVIS 4 0.0005
351 INGUINAL HERNIA 3 0.0005
352 METASTASES TO BONE 8 0.0005
353 HYPERURICAEMIA 2 0.0005
354 STAPHYLOCOCCAL INFECTION 16 0.0005
355 SPINAL COMPRESSION FRACTURE 4 0.0005
356 TRANSFUSION 5 0.0005
357 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
358 DIABETES MELLITUS 36 0.0005
359 PAIN 290 0.0005
360 NEUTROPENIA 64 0.0005
361 FEBRILE BONE MARROW APLASIA 2 0.0005
362 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
363 HYPOPHAGIA 12 0.0005
364 METASTATIC NEOPLASM 2 0.0005
365 HYSTERECTOMY 4 0.0005
366 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
367 CHAPPED LIPS 2 0.0005
368 MUCOSAL INFLAMMATION 12 0.0005
369 BEDRIDDEN 6 0.0005
370 CELLULITIS 23 0.0005
371 DYSPHEMIA 2 0.0005
372 PULMONARY CONGESTION 6 0.0005
373 GASTROINTESTINAL PAIN 5 0.0005
374 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
375 RED BLOOD CELL SEDIMENTATION RATE INCREASED 5 0.0005
376 CYTOMEGALOVIRUS VIRAEMIA 2 0.0004
377 SKIN INFECTION 5 0.0004
378 METASTASES TO LYMPH NODES 3 0.0004
379 MITRAL VALVE INCOMPETENCE 5 0.0004
380 TACHYPNOEA 6 0.0004
381 SEPSIS 49 0.0004
382 BLOOD TESTOSTERONE DECREASED 3 0.0004
383 SCAB 5 0.0004
384 SEPTIC SHOCK 19 0.0004
385 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
386 DROOLING 3 0.0004
387 INTENTIONAL PRODUCT MISUSE 38 0.0004
388 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
389 HYPOKALAEMIA 20 0.0004
390 MENTAL STATUS CHANGES 12 0.0004
391 ARTHRITIS INFECTIVE 2 0.0004
392 ERYTHEMA MULTIFORME 4 0.0004
393 DEFORMITY 4 0.0004
394 PULMONARY TOXICITY 3 0.0004
395 COVID-19 PNEUMONIA 5 0.0004
396 DIVERTICULUM 3 0.0004
397 BLOOD URINE PRESENT 8 0.0004
398 PROTEINURIA 8 0.0004
399 SUBDURAL HAEMATOMA 6 0.0004
400 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
401 HYPERLIPIDAEMIA 5 0.0004
402 CHILLS 49 0.0004
403 GASTROINTESTINAL TOXICITY 2 0.0004
404 DERMATITIS BULLOUS 3 0.0004
405 FAECES SOFT 3 0.0004
406 FIBROMYALGIA 10 0.0004
407 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
408 ARTHRITIS 32 0.0004
409 CARDIOMYOPATHY 6 0.0004
410 DRUG INEFFECTIVE 535 0.0004
411 OEDEMA 22 0.0004
412 URINARY INCONTINENCE 12 0.0004
413 HOSPICE CARE 4 0.0004
414 LIGAMENT SPRAIN 4 0.0004
415 EXPIRED DRUG ADMINISTERED 2 0.0004
416 MUCOUS STOOLS 2 0.0004
417 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
418 DELIRIUM 14 0.0004
419 PHARYNGITIS 5 0.0004
420 SUNBURN 3 0.0004
421 TOOTH EXTRACTION 5 0.0004
422 APPLICATION SITE SWELLING 2 0.0004
423 HYPERAMMONAEMIA 2 0.0004
424 ERYSIPELAS 2 0.0004
425 PRODUCT ADMINISTRATION ERROR 8 0.0004
426 HYPOTHERMIA 4 0.0004
427 OEDEMA PERIPHERAL 48 0.0004
428 SLUGGISHNESS 4 0.0004
429 OFF LABEL USE 343 0.0004
430 CEREBRAL ISCHAEMIA 2 0.0004
431 LEUKOCYTOSIS 7 0.0004
432 POOR VENOUS ACCESS 4 0.0004
433 HIATUS HERNIA 5 0.0004
434 HAEMORRHAGIC STROKE 3 0.0004
435 RESPIRATORY FAILURE 28 0.0004
436 HERPES ZOSTER 22 0.0004
437 AFFECTIVE DISORDER 3 0.0004
438 NAUSEA 302 0.0004
439 PRODUCT USE COMPLAINT 6 0.0004
440 BACK PAIN 88 0.0004
441 FURUNCLE 3 0.0004
442 BLOOD ALBUMIN DECREASED 3 0.0004
443 RENAL PAIN 4 0.0004
444 GINGIVAL PAIN 3 0.0004
445 RASH ERYTHEMATOUS 18 0.0004
446 ANAL FISTULA 2 0.0004
447 TRANSPLANT REJECTION 3 0.0004
448 PAIN OF SKIN 10 0.0004
449 GINGIVITIS 2 0.0004
450 MUSCLE DISORDER 3 0.0004
451 HYPOCALCAEMIA 7 0.0004
452 BLOOD POTASSIUM INCREASED 6 0.0004
453 NORMAL NEWBORN 2 0.0004
454 HYPERAESTHESIA 3 0.0004
455 INTESTINAL ISCHAEMIA 2 0.0004
456 HYPERKERATOSIS 2 0.0004
457 CYSTIC FIBROSIS 2 0.0004
458 DRUG ABUSE 30 0.0004
459 COAGULOPATHY 6 0.0004
460 BLOOD UREA INCREASED 6 0.0004
461 SKIN FISSURES 7 0.0004
462 BLOOD TEST ABNORMAL 5 0.0004
463 CHRONIC KIDNEY DISEASE 27 0.0004
464 MUSCULOSKELETAL STIFFNESS 31 0.0004
465 BLOOD CREATININE INCREASED 23 0.0004
466 SINUS TACHYCARDIA 5 0.0004
467 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
468 HAEMATURIA 12 0.0004
469 INTERNAL HAEMORRHAGE 4 0.0003
470 HYPERTONIA 2 0.0003
471 LETHARGY 20 0.0003
472 BLOOD URIC ACID INCREASED 2 0.0003
473 PYELONEPHRITIS 3 0.0003
474 PLEURAL EFFUSION 21 0.0003
475 TASTE DISORDER 7 0.0003
476 ECZEMA 18 0.0003
477 GASTROENTERITIS 5 0.0003
478 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
479 BLOOD IRON DECREASED 4 0.0003
480 CATARACT OPERATION 2 0.0003
481 IMPAIRED HEALING 11 0.0003
482 ANAL INCONTINENCE 3 0.0003
483 OSTEOMYELITIS 6 0.0003
484 VIRAL INFECTION 11 0.0003
485 PNEUMONITIS 9 0.0003
486 HEADACHE 207 0.0003
487 OSTEOPENIA 5 0.0003
488 EATING DISORDER 7 0.0003
489 CEREBRAL INFARCTION 8 0.0003
490 PNEUMONIA 106 0.0003
491 MUSCLE SPASTICITY 4 0.0003
492 IRON DEFICIENCY ANAEMIA 3 0.0003
493 HYPERCALCAEMIA 4 0.0003
494 OLIGURIA 2 0.0003
495 DEMENTIA 9 0.0003
496 ACUTE MYELOID LEUKAEMIA 5 0.0003
497 INFUSION SITE SWELLING 2 0.0003
498 BLEPHAROSPASM 2 0.0003
499 SPINAL DISORDER 3 0.0003
500 RENAL FAILURE 42 0.0003
501 ABSCESS 5 0.0003
502 PULMONARY OEDEMA 14 0.0003
503 ENTERITIS 2 0.0003
504 ACUTE RESPIRATORY FAILURE 6 0.0003
505 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
506 SINUS BRADYCARDIA 3 0.0003
507 ANAPHYLACTIC SHOCK 8 0.0003
508 DIZZINESS POSTURAL 3 0.0003
509 THROMBOTIC MICROANGIOPATHY 3 0.0003
510 AUTOIMMUNE DISORDER 3 0.0003
511 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
512 DEAFNESS 8 0.0003
513 RENAL TUBULAR NECROSIS 3 0.0003
514 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
515 HYPONATRAEMIA 17 0.0003
516 PRESCRIBED UNDERDOSE 6 0.0003
517 URINARY RETENTION 10 0.0003
518 DYSURIA 11 0.0003
519 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
520 TOXIC SKIN ERUPTION 3 0.0003
521 BONE MARROW FAILURE 6 0.0003
522 HEPATIC FUNCTION ABNORMAL 11 0.0003
523 INFARCTION 2 0.0003
524 EYE MOVEMENT DISORDER 2 0.0003
525 LYMPHOEDEMA 2 0.0003
526 EYE DISCHARGE 3 0.0003
527 ACUTE KIDNEY INJURY 44 0.0003
528 HYPOMAGNESAEMIA 4 0.0003
529 URINARY TRACT INFECTION 49 0.0003
530 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
531 ORTHOSTATIC HYPOTENSION 5 0.0003
532 HAEMOPTYSIS 8 0.0003
533 MASS 4 0.0003
534 HYPERKALAEMIA 10 0.0003
535 AMENORRHOEA 5 0.0003
536 ENCEPHALOPATHY 7 0.0003
537 OXYGEN SATURATION DECREASED 16 0.0003
538 FULL BLOOD COUNT ABNORMAL 3 0.0003
539 DUODENAL ULCER 2 0.0003
540 LYMPHADENOPATHY 10 0.0003
541 HEAD DISCOMFORT 5 0.0003
542 FLATULENCE 16 0.0003
543 GAIT DISTURBANCE 54 0.0003
544 RETCHING 6 0.0003
545 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
546 JOINT INJURY 6 0.0003
547 HYPERSOMNIA 8 0.0003
548 VOMITING 131 0.0003
549 HYPERTENSION 59 0.0003
550 IMPAIRED QUALITY OF LIFE 4 0.0003
551 OESOPHAGITIS 3 0.0003
552 ASPIRATION 3 0.0003
553 APPLICATION SITE PAIN 6 0.0003
554 DENTAL CARIES 3 0.0003
555 VENTRICULAR FIBRILLATION 3 0.0003
556 FUNGAL INFECTION 9 0.0003
557 SEIZURE 31 0.0003
558 THROMBOCYTOPENIA 30 0.0003
559 DIARRHOEA 173 0.0003
560 BACTERIAL INFECTION 5 0.0003
561 PSORIASIS 35 0.0003
562 BLISTER 15 0.0003
563 STATUS EPILEPTICUS 3 0.0003
564 BREAST TENDERNESS 2 0.0003
565 MYOCARDIAL ISCHAEMIA 3 0.0003
566 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
567 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
568 DEVICE FAILURE 4 0.0003
569 SLEEP APNOEA SYNDROME 5 0.0003
570 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
571 SEROTONIN SYNDROME 5 0.0003
572 DIFFUSE LARGE B-CELL LYMPHOMA 2 0.0003
573 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
574 ELECTROLYTE IMBALANCE 3 0.0003
575 BRONCHOPULMONARY ASPERGILLOSIS 2 0.0003
576 APHTHOUS ULCER 2 0.0003
577 EAR PAIN 5 0.0003
578 ABDOMINAL DISCOMFORT 43 0.0003
579 SPINAL PAIN 3 0.0003
580 SKIN LESION 7 0.0003
581 DIVERTICULITIS 7 0.0003
582 PNEUMOTHORAX 4 0.0003
583 ULCER 4 0.0003
584 CYSTITIS 8 0.0003
585 MUSCLE RIGIDITY 3 0.0003
586 PANCYTOPENIA 14 0.0003
587 BLOOD DISORDER 2 0.0002
588 OROPHARYNGEAL PAIN 23 0.0002
589 RHINORRHOEA 16 0.0002
590 STOMATITIS 15 0.0002
591 ADRENAL INSUFFICIENCY 3 0.0002
592 NEUTROPHIL COUNT DECREASED 10 0.0002
593 ABNORMAL FAECES 2 0.0002
594 CARDIOMEGALY 3 0.0002
595 HAEMOGLOBIN DECREASED 25 0.0002
596 OSTEONECROSIS OF JAW 6 0.0002
597 EYE SWELLING 9 0.0002
598 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
599 PERITONITIS 5 0.0002
600 ILEUS 3 0.0002
601 HEMIPLEGIA 2 0.0002
602 PULMONARY HYPERTENSION 5 0.0002
603 BRAIN OEDEMA 3 0.0002
604 MOUTH ULCERATION 5 0.0002
605 SKIN EXFOLIATION 20 0.0002
606 MUSCLE ATROPHY 3 0.0002
607 RESPIRATORY DISORDER 7 0.0002
608 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
609 ANURIA 2 0.0002
610 RASH 101 0.0002
611 HAEMATOMA 6 0.0002
612 MYOPATHY 2 0.0002
613 MULTI-ORGAN FAILURE 4 0.0002
614 ASTHENIA 87 0.0002
615 PRURITUS GENERALISED 5 0.0002
616 MUSCLE STRAIN 2 0.0002
617 DEEP VEIN THROMBOSIS 15 0.0002
618 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
619 FAECES DISCOLOURED 5 0.0002
620 CONDITION AGGRAVATED 70 0.0002
621 BURNING SENSATION 16 0.0002
622 BLOOD CALCIUM INCREASED 2 0.0002
623 IMMUNE SYSTEM DISORDER 3 0.0002
624 TOOTH INFECTION 3 0.0002
625 LUNG INFILTRATION 2 0.0002
626 DEHYDRATION 30 0.0002
627 LUNG DISORDER 11 0.0002
628 INFLUENZA 25 0.0002
629 HAEMOLYTIC ANAEMIA 2 0.0002
630 GASTROINTESTINAL INFECTION 2 0.0002
631 C-REACTIVE PROTEIN INCREASED 8 0.0002
632 BONE DISORDER 4 0.0002
633 EXOSTOSIS 2 0.0002
634 GRAND MAL CONVULSION 2 0.0002
635 BRONCHITIS 16 0.0002
636 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
637 FEELING COLD 6 0.0002
638 HEPATIC ENCEPHALOPATHY 2 0.0002
639 APPENDICITIS 2 0.0002
640 FLANK PAIN 2 0.0002
641 FALL 71 0.0002
642 CARDIAC FAILURE CONGESTIVE 17 0.0002
643 CARDIOGENIC SHOCK 3 0.0002
644 HERNIA 4 0.0002
645 HYPOKINESIA 3 0.0002
646 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
647 NEURALGIA 5 0.0002
648 ATRIAL FIBRILLATION 20 0.0002
649 CHOKING 4 0.0002
650 ORAL HERPES 4 0.0002
651 BONE PAIN 12 0.0002
652 HYPOTENSION 41 0.0002
653 ASCITES 6 0.0002
654 KIDNEY INFECTION 4 0.0002
655 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
656 ACUTE MYOCARDIAL INFARCTION 6 0.0002
657 SKIN HAEMORRHAGE 3 0.0002
658 DEPRESSED LEVEL OF CONSCIOUSNESS 8 0.0002
659 RENAL INJURY 6 0.0002
660 SINUS DISORDER 4 0.0002
661 BLADDER DISORDER 2 0.0002
662 PULMONARY MASS 3 0.0002
663 BLOOD PRESSURE ABNORMAL 4 0.0002
664 HAEMORRHAGE INTRACRANIAL 3 0.0002
665 PRODUCT DOSE OMISSION ISSUE 59 0.0002
666 EPISTAXIS 15 0.0002
667 HYPOAESTHESIA ORAL 3 0.0002
668 EMPHYSEMA 2 0.0002
669 HAEMATEMESIS 5 0.0002
670 PLATELET COUNT DECREASED 21 0.0002
671 EYELID PTOSIS 2 0.0002
672 NEUTROPHIL COUNT INCREASED 2 0.0002
673 ERECTILE DYSFUNCTION 5 0.0002
674 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
675 DECREASED APPETITE 45 0.0002
676 FEMUR FRACTURE 6 0.0002
677 HYPERBILIRUBINAEMIA 2 0.0002
678 DIPLOPIA 5 0.0002
679 HYPERGLYCAEMIA 7 0.0002
680 RESPIRATORY TRACT INFECTION 5 0.0002
681 POLLAKIURIA 8 0.0002
682 SEDATION 5 0.0002
683 APPLICATION SITE ERYTHEMA 5 0.0002
684 CYANOSIS 3 0.0002
685 FOLLICULITIS 2 0.0002
686 RENAL FAILURE ACUTE 8 0.0002
687 HIP FRACTURE 6 0.0002
688 DYSPNOEA EXERTIONAL 7 0.0002
689 SKIN CANCER 4 0.0002
690 HYPOGLYCAEMIA 9 0.0002
691 PALLOR 5 0.0002
692 CHEST PAIN 34 0.0002
693 MELAENA 4 0.0002
694 DRUG LEVEL INCREASED 3 0.0002
695 CYTOMEGALOVIRUS INFECTION 3 0.0002
696 STEVENS-JOHNSON SYNDROME 4 0.0002
697 MEDICATION ERROR 10 0.0002
698 WOUND 5 0.0002
699 RENAL IMPAIRMENT 15 0.0002
700 SNEEZING 4 0.0002
701 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
702 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
703 SCAR 3 0.0002
704 MYOCARDITIS 2 0.0002
705 CARDIAC FAILURE 14 0.0002
706 INFLAMMATION 9 0.0002
707 MUSCULOSKELETAL DISCOMFORT 3 0.0002
708 NEOPLASM 2 0.0002
709 SHOCK 4 0.0002
710 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
711 METASTASES TO LUNG 2 0.0002
712 PERICARDIAL EFFUSION 4 0.0002
713 INFECTION 25 0.0002
714 EYELID OEDEMA 2 0.0002
715 RENAL DISORDER 8 0.0002
716 BLOOD CHOLESTEROL INCREASED 8 0.0002
717 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
718 SYNCOPE 17 0.0002
719 TACHYCARDIA 15 0.0002
720 DRUG DEPENDENCE 27 0.0002
721 THIRST 3 0.0002
722 CHOLECYSTITIS 2 0.0002
723 BLOOD PRESSURE FLUCTUATION 4 0.0002
724 ARTHRALGIA 69 0.0002
725 TOOTHACHE 3 0.0002
726 BURSITIS 2 0.0002
727 NEOPLASM MALIGNANT 11 0.0002
728 NOCTURIA 2 0.0002
729 PANIC ATTACK 6 0.0002
730 GENERAL PHYSICAL HEALTH DETERIORATION 19 0.0002
731 DISCOMFORT 10 0.0002
732 EPILEPSY 5 0.0002
733 CYTOPENIA 2 0.0002
734 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
735 OVERDOSE 35 0.0002
736 GENERALISED OEDEMA 2 0.0002
737 CONFUSIONAL STATE 26 0.0002
738 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
739 COVID-19 28 0.0002
740 DYSARTHRIA 6 0.0002
741 DYSPHAGIA 15 0.0002
742 PULMONARY EMBOLISM 15 0.0002
743 METABOLIC ACIDOSIS 5 0.0002
744 SINUSITIS 16 0.0002
745 THERAPY NON-RESPONDER 7 0.0002
746 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
747 NIGHT SWEATS 5 0.0002
748 LACTIC ACIDOSIS 5 0.0002
749 ABDOMINAL DISTENSION 16 0.0002
750 SKIN IRRITATION 7 0.0002
751 SPEECH DISORDER 8 0.0002
752 NEPHROLITHIASIS 7 0.0002
753 UNDERDOSE 11 0.0002
754 SPINAL FRACTURE 3 0.0001
755 SWELLING 14 0.0001
756 MUSCULAR WEAKNESS 17 0.0001
757 HAIR TEXTURE ABNORMAL 2 0.0001
758 SOMNOLENCE 30 0.0001
759 LOSS OF CONSCIOUSNESS 19 0.0001
760 FOETAL EXPOSURE DURING PREGNANCY 12 0.0001
761 FLUSHING 15 0.0001
762 FEELING HOT 9 0.0001
763 IMPAIRED GASTRIC EMPTYING 2 0.0001
764 RIB FRACTURE 3 0.0001
765 PRURITUS 56 0.0001
766 APPLICATION SITE RASH 2 0.0001
767 INTERSTITIAL LUNG DISEASE 7 0.0001
768 BLOOD PRESSURE INCREASED 22 0.0001
769 PRODUCT USE ISSUE 27 0.0001
770 COUGH 40 0.0001
771 DEVICE OCCLUSION 2 0.0001
772 HALLUCINATION, VISUAL 3 0.0001
773 EYE PAIN 8 0.0001
774 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
775 PAIN IN JAW 4 0.0001
776 DIALYSIS 2 0.0001
777 DRY EYE 7 0.0001
778 BRONCHOSPASM 2 0.0001
779 HYPERSENSITIVITY 26 0.0001
780 LIVER FUNCTION TEST INCREASED 3 0.0001
781 ANGINA PECTORIS 4 0.0001
782 SWELLING FACE 9 0.0001
783 PRODUCT PRESCRIBING ISSUE 3 0.0001
784 FLUID RETENTION 7 0.0001
785 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
786 ACCIDENTAL OVERDOSE 5 0.0001
787 ANGIOEDEMA 6 0.0001
788 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
789 INJECTION SITE MASS 5 0.0001
790 TOOTH DISORDER 3 0.0001
791 IMMUNODEFICIENCY 2 0.0001
792 BLOOD POTASSIUM DECREASED 4 0.0001
793 HEART RATE IRREGULAR 3 0.0001
794 HOT FLUSH 10 0.0001
795 HEPATIC FAILURE 4 0.0001
796 INTESTINAL OBSTRUCTION 5 0.0001
797 APHASIA 4 0.0001
798 APPLICATION SITE PRURITUS 3 0.0001
799 CORONARY ARTERY DISEASE 4 0.0001
800 BRADYCARDIA 7 0.0001
801 ILL-DEFINED DISORDER 8 0.0001
802 HIP ARTHROPLASTY 2 0.0001
803 HOSPITALISATION 20 0.0001
804 MYALGIA 22 0.0001
805 MUSCULOSKELETAL CHEST PAIN 2 0.0001
806 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
807 PAIN IN EXTREMITY 38 0.0001
808 DELUSION 2 0.0001
809 EJECTION FRACTION DECREASED 2 0.0001
810 NERVOUS SYSTEM DISORDER 4 0.0001
811 SLEEP DISORDER 9 0.0001
812 DISEASE PROGRESSION 15 0.0001
813 DISORIENTATION 5 0.0001
814 DISEASE RECURRENCE 6 0.0001
815 COMA 6 0.0001
816 PRODUCT PRESCRIBING ERROR 3 0.0001
817 SKIN BURNING SENSATION 9 0.0001
818 MOBILITY DECREASED 9 0.0001
819 NECK PAIN 7 0.0001
820 HAEMORRHAGE 13 0.0001
821 HYPERHIDROSIS 16 0.0001
822 LOCALISED INFECTION 3 0.0001
823 FATIGUE 96 0.0001
824 DRY MOUTH 10 0.0001
825 CONVULSION 7 0.0001
826 LIVER INJURY 3 0.0001
827 DYSPNOEA 69 0.0001
828 EYE IRRITATION 7 0.0001
829 MANIA 2 0.0001
830 EXPIRED PRODUCT ADMINISTERED 4 0.0001
831 AGEUSIA 3 0.0001
832 ROAD TRAFFIC ACCIDENT 5 0.0001
833 NASOPHARYNGITIS 22 0.0001
834 ACNE 9 0.0001
835 CIRCULATORY COLLAPSE 2 0.0001
836 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
837 PERIPHERAL SWELLING 18 0.0001
838 INSOMNIA 31 0.0001
839 UNRESPONSIVE TO STIMULI 3 0.0001
840 BALANCE DISORDER 10 0.0001
841 DEVICE LEAKAGE 5 0.0001
842 MIGRAINE 11 0.0001
843 NEOPLASM PROGRESSION 4 0.0001
844 CONTUSION 11 0.0001
845 NEUROTOXICITY 2 0.0001
846 HEART RATE DECREASED 4 0.0001
847 METASTASES TO LIVER 2 0.0001
848 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
849 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
850 EAR INFECTION 3 0.0001
851 ALOPECIA 22 0.0001
852 CEREBRAL HAEMORRHAGE 4 0.0001
853 MYELOSUPPRESSION 4 0.0001
854 HEART RATE INCREASED 11 0.0001
855 GASTROENTERITIS VIRAL 2 0.0001
856 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
857 MEMORY IMPAIRMENT 15 0.0001
858 CARDIAC ARREST 9 0.0001
859 MUSCLE SPASMS 20 0.0001
860 SKIN DISCOLOURATION 5 0.0001
861 PARAESTHESIA 17 0.0001
862 AGRANULOCYTOSIS 2 0.0001
863 CHEST DISCOMFORT 11 0.0001
864 MIDDLE INSOMNIA 2 0.0001
865 ILLNESS 11 0.0001
866 BLOOD SODIUM DECREASED 2 0.0001
867 BLOOD PRESSURE DECREASED 7 0.0001
868 MUSCULOSKELETAL DISORDER 2 0.0001
869 RED BLOOD CELL COUNT DECREASED 3 0.0001
870 VISUAL IMPAIRMENT 13 0.0001
871 GLAUCOMA 2 0.0001
872 ERUCTATION 2 0.0001
873 LIVER FUNCTION TEST ABNORMAL 3 0.0001
874 DYSTONIA 2 0.0001
875 NEEDLE ISSUE 3 0.0001
876 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
877 DYSPHONIA 6 0.0001
878 SURGERY 6 0.0001
879 LABORATORY TEST ABNORMAL 3 0.0001
880 GASTROINTESTINAL DISORDER 9 0.0001
881 IRRITABILITY 6 0.0001
882 LACRIMATION INCREASED 3 0.0001
883 FULL BLOOD COUNT DECREASED 2 0.0001
884 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
885 THERAPEUTIC RESPONSE DECREASED 6 0.0001
886 DYSKINESIA 4 0.0001
887 ABDOMINAL PAIN UPPER 20 0.0001
888 CARDIAC DISORDER 9 0.0001
889 FEELING ABNORMAL 23 0.0001
890 CARDIO-RESPIRATORY ARREST 4 0.0001
891 DRUG-INDUCED LIVER INJURY 3 0.0001
892 URTICARIA 16 0.0001
893 WITHDRAWAL SYNDROME 4 0.0001
894 VISION BLURRED 13 0.0001
895 DRUG INTERACTION 15 0.0001
896 HYPOTHYROIDISM 3 0.0001
897 DRUG INTOLERANCE 9 0.0001
898 HYPOACUSIS 4 0.0001
899 HALLUCINATION 7 0.0001
900 DEPRESSION 21 0.0001
901 MENTAL DISORDER 4 0.0001
902 ANAPHYLACTIC REACTION 5 0.0001
903 BLOOD GLUCOSE INCREASED 17 0.0001
904 DIZZINESS 45 0.0001
905 LIP SWELLING 3 0.0001
906 GAIT INABILITY 3 0.0001
907 ASTHMA 10 0.0001
908 MUSCLE TWITCHING 2 0.0001
909 ARRHYTHMIA 4 0.0001
910 TREMOR 14 0.0001
911 THERAPY INTERRUPTED 6 0.0001
912 PRODUCTIVE COUGH 4 0.0001
913 BLOOD GLUCOSE DECREASED 4 0.0001
914 DIABETIC KETOACIDOSIS 2 0.0001
915 DRUG EFFECT INCOMPLETE 3 0.0001
916 DRY SKIN 11 0.0001
917 AGITATION 6 0.0001
918 DYSGEUSIA 6 0.0001
919 LEUKOPENIA 4 0.0001
920 GASTRIC CANCER 2 0.0001
921 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
922 HEPATITIS 2 0.0001
923 ANXIETY 22 0.0001
924 NERVOUSNESS 4 0.0001
925 DERMATITIS ATOPIC 4 0.0001
926 JOINT SWELLING 9 0.0001
927 MYOCARDIAL INFARCTION 13 0.0001
928 FEAR 2 0.0001
929 JAUNDICE 2 0.0001
930 DISTURBANCE IN ATTENTION 4 0.0001
931 DEVICE BREAKAGE 3 0.0001
932 RASH PRURITIC 4 0.0001
933 NEUROPATHY PERIPHERAL 7 0.0001
934 MULTIPLE SCLEROSIS RELAPSE 5 0.0001
935 TREATMENT FAILURE 6 0.0001
936 RHABDOMYOLYSIS 3 0.0001
937 DEVICE DISLOCATION 3 0.0001
938 NASAL CONGESTION 4 0.0001
939 CATARACT 4 0.0001
940 THROAT IRRITATION 3 0.0001
941 HYPOAESTHESIA 10 0.0001
942 EMOTIONAL DISTRESS 8 0.0001
943 VERTIGO 4 0.0001
944 DRUG ADMINISTRATION ERROR 2 0.0001
945 LIMB DISCOMFORT 2 0.0001
946 COGNITIVE DISORDER 3 0.0001
947 OCULAR HYPERAEMIA 3 0.0001
948 HEAD INJURY 2 0.0001
949 WEIGHT INCREASED 14 0.0001
950 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
951 THROMBOSIS 5 0.0001
952 EYE PRURITUS 2 0.0001
953 TOXICITY TO VARIOUS AGENTS 10 0.0001
954 PRODUCT QUALITY ISSUE 8 0.0001
955 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
956 GASTRIC DISORDER 2 0.0001
957 INJECTION SITE REACTION 4 0.0001
958 DEATH 50 0.0001
959 NIGHTMARE 2 0.0001
960 DEVICE USE ERROR 2 0.0001
961 DEVICE ISSUE 5 0.0001
962 INJECTION SITE PAIN 17 0.0001
963 CRYING 2 0.0001
964 UNEVALUABLE EVENT 4 0.0001
965 RHEUMATOID ARTHRITIS 6 0.0001
966 PALPITATIONS 6 0.0001
967 ABNORMAL BEHAVIOUR 2 0.0001
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
969 BLINDNESS 2 0.0000
970 EXPOSURE DURING PREGNANCY 3 0.0000
971 CEREBROVASCULAR ACCIDENT 8 0.0000
972 AMNESIA 3 0.0000
973 PRODUCT DOSE OMISSION 3 0.0000
974 DRUG WITHDRAWAL SYNDROME 4 0.0000
975 DEVICE MALFUNCTION 3 0.0000
976 INJURY 3 0.0000
977 COLORECTAL CANCER 2 0.0000
978 MULTIPLE SCLEROSIS 2 0.0000
979 AGGRESSION 2 0.0000
980 INCORRECT DOSE ADMINISTERED 9 0.0000
981 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
982 DEPRESSED MOOD 2 0.0000
983 INJECTION SITE BRUISING 3 0.0000
984 ADVERSE DRUG REACTION 3 0.0000
985 SUICIDAL IDEATION 3 0.0000
986 ADVERSE EVENT 3 0.0000
987 INJECTION SITE ERYTHEMA 4 0.0000
988 BREAST CANCER 3 0.0000
989 INJECTION SITE SWELLING 2 0.0000
990 INJECTION SITE HAEMORRHAGE 2 0.0000
991 INFLUENZA LIKE ILLNESS 2 0.0000
992 DRUG DOSE OMISSION 4 0.0000
993 NO ADVERSE EVENT 4 0.0000